EBS Emergent BioSolutions Inc.
NYSE · SEC CIK 1367644 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $1.42M 10 sales by 7 insiders
- Filings on record
- 205 since 2021-11-15, latest 2026-07-02 12:57
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| DeGolyer Donald W | Dir | — | $317.6K |
| Glessner Coleen | EVP, Quality, Ethics, CPL | — | $306.1K |
| Richard Ronald | Dir | — | $263.1K |
| Dayal Sujata Tyagi | Dir | — | $201.1K |
| Zoon Kathryn C | Dir | — | $144.5K |
| Katkin Keith | Dir | — | $128.2K |
| Williams Paul Anthony | SVP, Products Business | — | $59.0K |
| Lowry Simon C | SVP, CMO, R, D | — | — |
| Perl Jessica | SVP, GC, Corp Sec | — | — |
| Hartzel William | SVP, Bioservices | — | — |
Transactions 225
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-02 12:57 | 2026-07-01 | EBS | Williams Paul Anthony | SVP, Products Business | S - Sale | $8.40 | -3,000 | 159.1K | -2% | -$25.2K |
| 2026-06-10 15:09 | 2026-06-08 | EBS | Williams Paul Anthony | SVP, Products Business | F - Tax | $8.00 | -694 | 162.1K | -0.4% | -$5,552 | |
| 2026-06-10 15:08 | 2026-06-08 | EBS | LINDAHL RICHARD S | EVP, CFO | F - Tax | $8.00 | -3,964 | 374.1K | -1% | -$31.7K | |
| 2026-06-10 15:07 | 2026-06-08 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $8.00 | -2,018 | 202.2K | -1.0% | -$16.1K | |
| 2026-06-10 15:05 | 2026-06-08 | EBS | Hartzel William | SVP, Bioservices | F - Tax | $8.00 | -1,741 | 185.6K | -0.9% | -$13.9K | |
| DT | 2026-05-04 17:30 | 2026-04-30 | EBS | Dayal Sujata Tyagi | Dir | A - Grant | $0.00 | +25.3K | 114.3K | +28% | $0 |
| DMT | 2026-05-04 17:30 | 2026-05-01 | EBS | Dayal Sujata Tyagi | Dir | S - Sale | $8.40 | -13.8K | 100.6K | -12% | -$115.6K |
| DT | 2026-05-04 17:30 | 2026-04-30 | EBS | DeGolyer Donald W | Dir | A - Grant | $0.00 | +25.3K | 145.2K | +21% | $0 |
| DMT | 2026-05-04 17:30 | 2026-05-01 | EBS | DeGolyer Donald W | Dir | S - Sale | $8.40 | -15.5K | 129.7K | -11% | -$130.0K |
| DT | 2026-05-04 17:29 | 2026-04-30 | EBS | Katkin Keith | Dir | A - Grant | $0.00 | +25.3K | 111.8K | +29% | $0 |
| DT | 2026-05-04 17:29 | 2026-04-30 | EBS | Katkin Keith | Dir | S - Sale | $8.28 | -15.5K | 96.3K | -14% | -$128.2K |
| D | 2026-05-04 17:29 | 2026-04-30 | EBS | White Marvin L | Dir | A - Grant | $0.00 | +25.3K | 113.8K | +29% | $0 |
| D | 2026-05-04 17:29 | 2026-04-30 | EBS | FOWLER JOHN D JR | Dir | A - Grant | $0.00 | +25.3K | 30.4K | +506% | $0 |
| D | 2026-05-04 17:28 | 2026-04-30 | EBS | Richard Ronald | Dir | A - Grant | $0.00 | +25.3K | 123.8K | +26% | $0 |
| DT | 2026-05-04 17:28 | 2026-04-30 | EBS | Zoon Kathryn C | Dir | A - Grant | $0.00 | +25.3K | 97.1K | +35% | $0 |
| DMT | 2026-05-04 17:28 | 2026-05-01 | EBS | Zoon Kathryn C | Dir | S - Sale | $8.40 | -17.2K | 79.9K | -18% | -$144.5K |
| D | 2026-05-04 17:27 | 2026-04-30 | EBS | Fowler Neal Franklin | Dir | A - Grant | $0.00 | +25.3K | 160.8K | +19% | $0 |
| D | 2026-05-04 17:23 | 2026-04-30 | EBS | Harsanyi Zsolt | COB, Dir | A - Grant | $0.00 | +25.3K | 149.1K | +20% | $0 |
| 2026-05-01 16:30 | 2026-04-29 | EBS | Williams Paul Anthony | SVP, Products Business | A - Grant | $0.00 | +100.1K | 162.8K | +160% | $0 | |
| 2026-05-01 16:29 | 2026-04-29 | EBS | Lowry Simon C | SVP, CMO, R, D | A - Grant | $0.00 | +100.1K | 177.9K | +129% | $0 | |
| 2026-05-01 16:28 | 2026-04-29 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | A - Grant | $0.00 | +100.1K | 204.2K | +96% | $0 | |
| 2026-05-01 16:27 | 2026-04-29 | EBS | LINDAHL RICHARD S | EVP, CFO | A - Grant | $0.00 | +162.7K | 378.0K | +76% | $0 | |
| 2026-05-01 16:27 | 2026-04-29 | EBS | Perl Jessica | SVP, GC, Corp Sec | A - Grant | $0.00 | +104.3K | 165.3K | +171% | $0 | |
| 2026-05-01 16:26 | 2026-04-29 | EBS | Hartzel William | SVP, Bioservices | A - Grant | $0.00 | +100.1K | 187.3K | +115% | $0 | |
| 2026-05-01 16:26 | 2026-04-29 | EBS | PAPA JOSEPH C | Pres, CEO, Dir | A - Grant | $0.00 | +187.7K | 493.2K | +61% | $0 | |
| T | 2026-04-03 16:05 | 2026-04-01 | EBS | Williams Paul Anthony | SVP, Products Business | S - Sale | $8.44 | -4,000 | 62.7K | -6% | -$33.8K |
| D | 2026-03-05 | 2026-03-05 | EBS | Lowry Simon C | SVP, CMO, R, D | F - Tax | $8.44 | -10.6K | 77.8K | -12% | -$89.8K |
| D | 2026-03-05 | 2026-03-05 | EBS | LINDAHL RICHARD S | EVP, CFO | F - Tax | $8.44 | -23.6K | 215.4K | -10% | -$199.6K |
| D | 2026-03-05 | 2026-03-05 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $8.44 | -8,199 | 104.1K | -7% | -$69.2K |
| 2026-03-05 | 2026-03-03 | EBS | FOWLER JOHN D JR | Dir | A - Grant | $8.99 | +5,006 | 5,006 | New | +$45.0K | |
| D | 2026-03-05 | 2026-03-05 | EBS | Hartzel William | SVP, Bioservices | F - Tax | $8.44 | -9,493 | 87.2K | -10% | -$80.1K |
| D | 2026-03-05 | 2026-03-05 | EBS | PAPA JOSEPH C | Pres, CEO, Dir | F - Tax | $8.44 | -37.1K | 305.4K | -11% | -$312.7K |
| D | 2026-03-05 | 2026-03-05 | EBS | Perl Jessica | SVP, GC, Corp Sec | F - Tax | $8.44 | -6,465 | 61.0K | -10% | -$54.6K |
| D | 2026-03-05 | 2026-03-05 | EBS | Williams Paul Anthony | SVP, Products Business | F - Tax | $8.44 | -9,397 | 66.7K | -12% | -$79.3K |
| 2026-03-03 | 2026-03-01 | EBS | LINDAHL RICHARD S | EVP, CFO | F - Tax | $8.15 | -683 | 239.0K | -0.3% | -$5,566 | |
| 2026-03-03 | 2026-03-01 | EBS | Williams Paul Anthony | SVP, Products Business | F - Tax | $8.15 | -116 | 76.1K | -0.2% | -$945.40 | |
| 2026-03-03 | 2026-03-01 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $8.15 | -313 | 112.3K | -0.3% | -$2,551 | |
| 2026-02-10 | 2026-02-09 | EBS | Perl Jessica | SVP, GC, Corp Sec | F - Tax | $11.03 | -918 | 67.5K | -1% | -$10.1K | |
| 2026-02-10 | 2026-02-06 | EBS | LINDAHL RICHARD S | EVP, CFO | D - Sale to Iss | $10.92 | -46.2K | 245.3K | -16% | -$504.0K | |
| 2026-02-10 | 2026-02-06 | EBS | LINDAHL RICHARD S | EVP, CFO | F - Tax | $10.92 | -5,642 | 239.7K | -2% | -$61.6K | |
| 2026-02-10 | 2026-02-06 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | D - Sale to Iss | $10.92 | -28.8K | 115.5K | -20% | -$315.0K | |
| 2026-02-10 | 2026-02-06 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $10.92 | -2,852 | 112.6K | -2% | -$31.1K | |
| 2026-02-10 | 2026-02-06 | EBS | Williams Paul Anthony | SVP, Products Business | D - Sale to Iss | $10.92 | -8,655 | 77.2K | -10% | -$94.5K | |
| 2026-02-10 | 2026-02-06 | EBS | Williams Paul Anthony | SVP, Products Business | F - Tax | $10.92 | -1,022 | 76.2K | -1% | -$11.2K | |
| 2026-02-10 | 2026-02-06 | EBS | Hartzel William | SVP, Bioservices | D - Sale to Iss | $10.92 | -5,771 | 97.3K | -6% | -$63.0K | |
| 2026-02-10 | 2026-02-06 | EBS | Hartzel William | SVP, Bioservices | F - Tax | $10.92 | -630 | 96.7K | -0.6% | -$6,880 | |
| 2025-12-16 | 2025-12-14 | EBS | Lowry Simon C | SVP, CMO, R, D | F - Tax | $11.41 | -3,543 | 88.4K | -4% | -$40.4K | |
| DM | 2025-12-09 | 2025-12-05 | EBS | Richard Ronald | Dir | S - Sale+OE | $11.97 | -22.0K | 98.4K | -18% | -$263.1K |
| D | 2025-12-09 | 2025-12-05 | EBS | Richard Ronald | Dir | F - Tax | $11.90 | -10.9K | 113.3K | -9% | -$129.3K |
| D | 2025-12-09 | 2025-12-05 | EBS | Richard Ronald | Dir | M - OptEx | $5.02 | +25.7K | 124.2K | +26% | +$129.3K |
| 2025-11-13 | 2025-11-11 | EBS | Hartzel William | SVP, Bioservices | F - Tax | $10.88 | -610 | 103.1K | -0.6% | -$6,637 | |
| 2025-11-12 | 2025-11-10 | EBS | DeGolyer Donald W | Dir | S - Sale | $10.54 | -17.8K | 119.9K | -13% | -$187.6K | |
| 2025-11-10 | 2025-11-07 | EBS | Dayal Sujata Tyagi | Dir | S - Sale | $10.00 | -8,552 | 89.0K | -9% | -$85.5K | |
| 2025-10-17 | 2025-10-15 | EBS | LINDAHL RICHARD S | EVP, CFO | F - Tax | $9.60 | -4,995 | 291.5K | -2% | -$48.0K | |
| 2025-10-16 | 2025-10-07 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | S - Sale | $10.00 | -30.6K | 144.3K | -17% | -$306.1K | |
| 2025-08-18 | 2025-08-15 | EBS | Zoon Kathryn C | Dir | S - Sale | $8.87 | -7,086 | 71.8K | -9% | -$62.9K | |
| 2025-08-13 | 2025-08-12 | EBS | DeGolyer Donald W | Dir | S - Sale | $8.65 | -7,844 | 137.7K | -5% | -$67.9K | |
| 2025-07-15 | 2025-07-11 | EBS | Hartzel William | SVP, Bioservices | F - Tax | $7.36 | -4,263 | 103.7K | -4% | -$31.4K | |
| 2025-06-10 | 2025-06-08 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $6.63 | -1,249 | 174.9K | -0.7% | -$8,281 | |
| 2025-06-10 | 2025-06-08 | EBS | Williams Paul Anthony | SVP, Products Business | F - Tax | $6.63 | -464 | 85.9K | -0.5% | -$3,076 | |
| 2025-06-10 | 2025-06-08 | EBS | Hartzel William | SVP, Bioservices | F - Tax | $6.63 | -1,167 | 108.0K | -1% | -$7,737 | |
| 2025-06-10 | 2025-06-08 | EBS | LINDAHL RICHARD S | EVP, CFO | F - Tax | $6.63 | -2,733 | 296.5K | -0.9% | -$18.1K | |
| 2025-05-28 | 2025-05-23 | EBS | Katkin Keith | Dir | S - Sale | $6.30 | -7,844 | 86.4K | -8% | -$49.4K | |
| 2025-05-15 | 2025-05-13 | EBS | PAPA JOSEPH C | Pres, CEO, Dir | P - Purchase | $5.83 | +60.0K | 342.5K | +21% | +$349.8K | |
| D | 2025-05-02 | 2025-04-30 | EBS | Zoon Kathryn C | Dir | A - Grant | $0.00 | +34.4K | 78.9K | +77% | $0 |
| D | 2025-05-02 | 2025-04-30 | EBS | Richard Ronald | Dir | A - Grant | $0.00 | +34.4K | 105.5K | +48% | $0 |
| D | 2025-05-02 | 2025-04-30 | EBS | Fowler Neal Franklin | Dir | A - Grant | $0.00 | +34.4K | 135.5K | +34% | $0 |
| D | 2025-05-02 | 2025-04-30 | EBS | DeGolyer Donald W | Dir | A - Grant | $0.00 | +34.4K | 145.5K | +31% | $0 |
| D | 2025-05-02 | 2025-04-30 | EBS | Harsanyi Zsolt | COB, Dir | A - Grant | $0.00 | +34.4K | 123.7K | +39% | $0 |
| D | 2025-05-02 | 2025-04-30 | EBS | White Marvin L | Dir | A - Grant | $0.00 | +34.4K | 88.5K | +64% | $0 |
| D | 2025-05-02 | 2025-04-30 | EBS | Katkin Keith | Dir | A - Grant | $0.00 | +34.4K | 94.3K | +57% | $0 |
| D | 2025-05-02 | 2025-04-30 | EBS | SULLIVAN LOUIS W | Dir | A - Grant | $0.00 | +34.4K | 139.1K | +33% | $0 |
| D | 2025-05-02 | 2025-04-30 | EBS | Dayal Sujata Tyagi | Dir | A - Grant | $0.00 | +34.4K | 97.5K | +54% | $0 |
| A | 2025-04-09 | 2025-03-06 | EBS | Hartzel William | SVP, Bioservices | A - Grant | $0.00 | +62.5K | 109.7K | +132% | $0 |
| 2025-04-09 | 2025-04-07 | EBS | Hartzel William | SVP, Bioservices | F - Tax | $4.44 | -561 | 109.1K | -0.5% | -$2,491 | |
| 2025-04-09 | 2025-04-07 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $4.44 | -480 | 176.2K | -0.3% | -$2,131 | |
| 2025-03-12 | 2025-03-12 | EBS | Fowler Neal Franklin | Dir | S - Sale | $5.83 | -35.0K | 101.1K | -26% | -$204.1K | |
| 2025-03-12 | 2025-03-12 | EBS | Zoon Kathryn C | Dir | S - Sale | $5.73 | -10.0K | 44.5K | -18% | -$57.3K | |
| D | 2025-03-10 | 2025-03-06 | EBS | Williams Paul Anthony | SVP, Products Business | A - Grant | $0.00 | +62.5K | 86.3K | +262% | $0 |
| D | 2025-03-10 | 2025-03-06 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | A - Grant | $0.00 | +62.5K | 176.7K | +55% | $0 |
| D | 2025-03-10 | 2025-03-06 | EBS | Lowry Simon C | SVP, CMO, R, D | A - Grant | $0.00 | +62.5K | 92.0K | +212% | $0 |
| D | 2025-03-10 | 2025-03-06 | EBS | PAPA JOSEPH C | Pres, CEO, Dir | A - Grant | $0.00 | +282.5K | 282.5K | New | $0 |
| D | 2025-03-10 | 2025-03-06 | EBS | Perl Jessica | SVP, GC, Corp Sec | A - Grant | $0.00 | +62.5K | 68.4K | +1,062% | $0 |
| D | 2025-03-10 | 2025-03-06 | EBS | Hartzel William | SVP, Bioservices | A - Grant | $0.00 | +62.5K | 110.0K | +132% | $0 |
| D | 2025-03-10 | 2025-03-06 | EBS | LINDAHL RICHARD S | EVP, CFO | A - Grant | $0.00 | +146.9K | 299.2K | +96% | $0 |
| 2025-03-07 | 2025-03-05 | EBS | Hartzel William | SVP, Bioservices | F - Tax | $5.80 | -292 | 47.2K | -0.6% | -$1,694 | |
| M | 2025-03-04 | 2025-02-28+ | EBS | Williams Paul Anthony | SVP, Products Business | F - Tax | $7.48 | -498 | 24.0K | -2% | -$3,725 |
| 2025-03-04 | 2025-02-12 | EBS | LINDAHL RICHARD S | EVP, CFO | D - Sale to Iss | $0.00 | -16.9K | 154.1K | -10% | $0 | |
| M | 2025-03-04 | 2025-02-28+ | EBS | LINDAHL RICHARD S | EVP, CFO | F - Tax | $7.48 | -1,756 | 153.0K | -1% | -$13.1K |
| M | 2025-03-04 | 2025-02-12 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | D - Sale to Iss | $0.00 | -30.0K | 138.5K | -18% | $0 |
| 2025-03-04 | 2025-03-01 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $7.48 | -313 | 114.2K | -0.3% | -$2,341 | |
| 2025-02-11 | 2025-02-09 | EBS | Perl Jessica | SVP, GC, Corp Sec | F - Tax | $10.00 | -918 | 5,887 | -13% | -$9,180 | |
| D | 2024-12-17 | 2024-12-15 | EBS | Lowry Simon C | SVP, CMO, R, D | A - Grant | $0.00 | +29.5K | 29.5K | New | $0 |
| 2024-12-10 | 2024-12-08 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $9.01 | -18.7K | 144.5K | -11% | -$168.3K | |
| 2024-11-14 | 2024-11-12 | EBS | DeGolyer Donald W | Dir | S - Sale | $10.91 | -25.0K | 111.1K | -18% | -$272.8K | |
| 2024-11-13 | 2024-11-11 | EBS | White Marvin L | Dir | S - Sale | $11.97 | -14.3K | 54.1K | -21% | -$171.0K | |
| 2024-11-13 | 2024-11-11 | EBS | Hartzel William | SVP, Bioservices | F - Tax | $11.97 | -632 | 47.5K | -1% | -$7,565 | |
| 2024-10-17 | 2024-10-15 | EBS | LINDAHL RICHARD S | EVP, CFO | A - Grant | $0.00 | +15.0K | 171.0K | +10% | $0 | |
| 2024-07-12 | 2024-07-11 | EBS | Hartzel William | SVP, Bioservices | A - Grant | $0.00 | +15.0K | 48.1K | +45% | $0 | |
| 2024-07-12 | 2024-07-11 | EBS | Fox Jennifer Lynne | EVP, GC, Ext Aff, Corp Sec | A - Grant | $0.00 | +15.0K | 186.4K | +9% | $0 |
Purchase Sale Sale after option exercise All abbreviations